Compound Detail
CHEMBL20252
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL20252 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UDHQGXCXSRGAPA-UHFFFAOYSA-N |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
14
Publications
0
Known Names
Molecular Properties
431.5
MW (Da)
6.00
ALogP
5
HBA
2
HBD
79.8
PSA (Ų)
0.36
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 7.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Platelet-derived growth factor receptor CHEMBL2095189 | IC50 | 7.3 | 7.3 | 50.0 | 2 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Bcr/Abl fusion protein CHEMBL2096618 | IC50 | 6.7 | 6.7 | 199.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Platelet-derived growth factor receptor | IC50 | = | 50.0 | nM | 7.3 | Inhibition of tyrosine kinase(PDGF-R) | - |
| Platelet-derived growth factor receptor | IC50 | = | 50.0 | nM | 7.3 | Inhibition of the platelet-derived growth factor receptor. | - |
| Tyrosine-protein kinase ABL1 | IC50 | = | 200.0 | nM | 6.7 | Inhibition of v-Abl tyrosine kinase. | - |
| Bcr/Abl fusion protein | IC50 | = | 199.53 | nM | 6.7 | Inhibition of BCR-ABL kinase (unknown origin) | 23473682 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/0960-894X(96)00197-7 | Platelet-derived growth factor receptor | 1 |
| - | 10.1016/0960-894X(96)00197-7 | Epidermal growth factor receptor | 1 |
| - | 10.1016/0960-894X(96)00197-7 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| - | 10.1016/0960-894X(96)00197-7 | Protein kinase C alpha type | 1 |
| - | 10.1016/0960-894X(96)00197-7 | Protein kinase C delta type | 1 |
| - | 10.1016/0960-894X(96)00197-7 | cAMP-dependent protein kinase (PKA) | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Tyrosine-protein kinase ABL1 | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Epidermal growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Platelet-derived growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | cAMP-dependent protein kinase (PKA) | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C alpha type | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C delta type | 1 |
| 23473682 | 10.1016/j.bmcl.2013.01.113 | Bcr/Abl fusion protein | 1 |
Data from ChEMBL 36 via Core Engine